Ociperlimab (Synonyms: BGB-A1217) |
| Katalog-Nr.GC69604 |
Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds with high affinity to the extracellular domain of human TIGIT (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used for cancer research.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2342597-93-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Ociperlimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Ociperlimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *